Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Short Interest Update

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) saw a significant growth in short interest during the month of November. As of November 30th, there was short interest totalling 121,500 shares, a growth of 40.0% from the November 15th total of 86,800 shares. Based on an average daily volume of 81,500 shares, the short-interest ratio is presently 1.5 days.

Ekso Bionics Stock Performance

Shares of EKSO opened at $0.57 on Friday. The company has a market cap of $12.47 million, a PE ratio of -0.87 and a beta of 1.43. The firm has a 50-day moving average of $0.84 and a 200-day moving average of $1.02. Ekso Bionics has a one year low of $0.50 and a one year high of $3.13. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.81 and a quick ratio of 2.14.

Ekso Bionics (NASDAQ:EKSO) last posted its quarterly earnings results on Monday, October 28th. The company reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.02). The business had revenue of $4.13 million for the quarter, compared to the consensus estimate of $6.00 million. Ekso Bionics had a negative return on equity of 83.09% and a negative net margin of 62.95%. During the same quarter in the previous year, the business posted ($0.24) EPS. As a group, equities analysts forecast that Ekso Bionics will post -0.48 earnings per share for the current year.

Analyst Ratings Changes

EKSO has been the topic of several analyst reports. Lake Street Capital cut their price target on shares of Ekso Bionics from $2.50 to $2.00 and set a “buy” rating on the stock in a research report on Tuesday, October 29th. HC Wainwright reduced their price target on Ekso Bionics from $10.00 to $9.00 and set a “buy” rating for the company in a research report on Tuesday, October 29th. Finally, StockNews.com initiated coverage on Ekso Bionics in a research report on Friday. They set a “hold” rating on the stock.

Ekso Bionics Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.